129 related articles for article (PubMed ID: 1828459)
1. Modulation of endothelin effects on blood pressure and hematocrit by atrial natriuretic peptide.
Valentin JP; Gardner DG; Wiedemann E; Humphreys MH
Hypertension; 1991 Jun; 17(6 Pt 2):864-9. PubMed ID: 1828459
[TBL] [Abstract][Full Text] [Related]
2. [Extravascular transfer of fluids and proteins induced by endothelin in the binephrectomized rat].
Valentin JP; Gardner DG; Ribstein J; Mimran A; Humphreys MH
Arch Mal Coeur Vaiss; 1991 Aug; 84(8):1159-62. PubMed ID: 1835358
[TBL] [Abstract][Full Text] [Related]
3. Modulation of ANP-dependent effects of endothelin by inhibitors of neutral endopeptidase and cGMP phosphodiesterase.
Valentin JP; Qiu C; Wiedemann E; Gardner DG; Humphreys MH
J Pharmacol Exp Ther; 1995 May; 273(2):744-52. PubMed ID: 7752077
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of neutral endopeptidase amplifies the effects of endogenous atrial natriuretic peptide on blood pressure and fluid partition.
Valentin JP; Qiu CB; Wiedemann E; Gardner D; Humphreys MH
Am J Hypertens; 1992 Feb; 5(2):88-91. PubMed ID: 1532317
[TBL] [Abstract][Full Text] [Related]
5. Influence of dopamine receptor and adrenoceptor blockade on the hemoconcentrating and hypotensive actions of atrial natriuretic peptide.
Valentin JP; Ribstein J; Nafrialdi N; Mimran A
Can J Physiol Pharmacol; 1997 Sep; 75(9):1142-7. PubMed ID: 9365827
[TBL] [Abstract][Full Text] [Related]
6. Endothelin antiserum decreases volume-stimulated and basal plasma concentration of atrial natriuretic peptide.
Fyhrquist F; Sirviö ML; Helin K; Saijonmaa O; Metsärinne K; Paakkari I; Järvinen A; Tikkanen I
Circulation; 1993 Sep; 88(3):1172-6. PubMed ID: 8353879
[TBL] [Abstract][Full Text] [Related]
7. Dose-dependence and reversibility of the hemoconcentrating and hypotensive activities of atrial natriuretic peptide in binephrectomized rats.
Valentin JP; Sechi LA
Fundam Clin Pharmacol; 1994; 8(3):238-45. PubMed ID: 7927119
[TBL] [Abstract][Full Text] [Related]
8. Positive inotropic action, natriuresis and atrial natriuretic factor release induced by endothelin in the conscious rat.
Garcia R; Lachance D; Thibault G
J Hypertens; 1990 Aug; 8(8):725-31. PubMed ID: 2170512
[TBL] [Abstract][Full Text] [Related]
9. Effect of nicardipine and atriopeptin on transcapillary shift of fluid and proteins.
Valentin JP; Ribstein J; Mimran A
Am J Physiol; 1989 Jul; 257(1 Pt 2):R174-9. PubMed ID: 2526593
[TBL] [Abstract][Full Text] [Related]
10. Endothelin stimulates basal and stretch-induced atrial natriuretic peptide secretion from the perfused rat heart.
Mäntymaa P; Leppäluoto J; Ruskoaho H
Endocrinology; 1990 Jan; 126(1):587-95. PubMed ID: 2136728
[TBL] [Abstract][Full Text] [Related]
11. Pressor hormones regulate atrial-stretch-induced release of atrial natriuretic peptide in the pithed rat.
Ruskoaho H; Vakkuri O; Arjamaa O; Vuolteenaho O; Leppäluoto J
Circ Res; 1989 Mar; 64(3):482-92. PubMed ID: 2563674
[TBL] [Abstract][Full Text] [Related]
12. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand.
Kukkonen P; Vuolteenaho O; Ruskoaho H
Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129
[TBL] [Abstract][Full Text] [Related]
13. A role for atrial natriuretic peptide in endothelin-induced natriuresis.
Munger KA; Sugiura M; Takahashi K; Inagami T; Badr KF
J Am Soc Nephrol; 1991 Jun; 1(12):1278-83. PubMed ID: 1832979
[TBL] [Abstract][Full Text] [Related]
14. Blunted effect of ANP on hematocrit and plasma volume in streptozotocin-induced diabetes mellitus in rats.
Valentin JP; Sechi LA; Humphreys MH
Am J Physiol; 1994 Feb; 266(2 Pt 2):R584-91. PubMed ID: 8141419
[TBL] [Abstract][Full Text] [Related]
15. [Modulating effects of atrial natriuretic peptide on vascular permeability and blood pressure by inhibition of cyclic phosphodiesterase GMP in the rat].
Valentin JP; Humphreys MH
Arch Mal Coeur Vaiss; 1992 Aug; 85(8):1219-22. PubMed ID: 1336359
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of opioid-induced atrial natriuretic peptide release in conscious rats.
Pesonen A; Leppäluoto J; Ruskoaho H
J Pharmacol Exp Ther; 1990 Aug; 254(2):690-5. PubMed ID: 2143537
[TBL] [Abstract][Full Text] [Related]
17. Atrial natriuretic peptide (ANP) inhibits its own secretion via ANP(A) receptors: altered effect in experimental hypertension.
Leskinen H; Vuolteenaho O; Toth M; Ruskoaho H
Endocrinology; 1997 May; 138(5):1893-902. PubMed ID: 9112384
[TBL] [Abstract][Full Text] [Related]
18. Extrarenal resistance to atrial natriuretic peptide in rats with experimental nephrotic syndrome.
Valentin JP; Ying WZ; Couser WG; Humphreys MH
Am J Physiol; 1998 Mar; 274(3):F556-63. PubMed ID: 9530272
[TBL] [Abstract][Full Text] [Related]
19. Staurosporine, a protein kinase C inhibitor, inhibits atrial natriuretic peptide secretion induced by sarafotoxin, endothelin and phorbol ester.
Pitkänen M; Mäntymaa P; Ruskoaho H
Eur J Pharmacol; 1991 Apr; 195(3):307-15. PubMed ID: 1831134
[TBL] [Abstract][Full Text] [Related]
20. Combined inhibition of endothelin and angiotensin II receptors blocks volume load-induced cardiac hormone release.
Leskinen H; Vuolteenaho O; Ruskoaho H
Circ Res; 1997 Jan; 80(1):114-23. PubMed ID: 8978330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
